Search

Your search keyword '"John, E.M. (Esther)"' showing total 44 results

Search Constraints

Start Over You searched for: Author "John, E.M. (Esther)" Remove constraint Author: "John, E.M. (Esther)"
44 results on '"John, E.M. (Esther)"'

Search Results

1. An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

2. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations

3. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

4. The CHEK2 variant C.349A>G is associated with prostate cancer risk and carriers share a common ancestor

5. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

6. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

7. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

8. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

9. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

10. Erratum: Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature communications (2019) 10 1 (431))

11. Large-scale transcriptome-wide association study identifies new prostate cancer risk regions

12. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

13. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

14. Genetic modifiers of CHEK2∗1100delC-associated breast cancer risk

15. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

16. Age-And tumor subtype-specific breast cancer risk estimates for CHEK2∗1100delC Carriers

17. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

18. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

19. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

20. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

21. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

22. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

23. Prediction of breast cancer risk based on profiling with common genetic variants

24. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

25. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

26. Assessing associations between the AURKAHMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

27. DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

28. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

29. Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

30. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

31. A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers

32. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

33. 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: Evidence from the Breast Cancer Association Consortium

34. CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer

35. 19p13.1 Is a triple-negative-specific breast cancer susceptibility locus

36. Comparison of 6q25 breast cancer hits from Asian and European genome wide association studies in the Breast Cancer Association consortium (BCAC)

37. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

38. Confirmation of 5p12 as a susceptibility locus for progesterone-receptor- positive, lower grade breast cancer

39. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

40. Exploring the link between MORF4L1 and risk of breast cancer

41. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

42. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

43. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction

44. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2 (CIMBA)

Catalog

Books, media, physical & digital resources